Trump announces 100% chip tariff as Apple ups U.S. investment
Michael Cannon-Brookes, CEO and Co-Founder of Atlassian Corp (NASDAQ:TEAM), recently sold a significant portion of his holdings in the company. According to the latest filing, Cannon-Brookes disposed of shares amounting to a total of $2,010,942. The transactions occurred on January 17, 2025, with the sale prices ranging from $252.14 to $258.43 per share. The sale comes as Atlassian, currently valued at $65.67 billion, maintains impressive gross profit margins of 81.55%. According to InvestingPro analysis, the stock is trading above its Fair Value.
The shares were sold under a Rule 10b5-1 trading plan, which Cannon-Brookes adopted on February 8, 2024. Following these transactions, he retains ownership of 389,452 shares, held by CBC Co Pty Limited as trustee for the Cannon-Brookes Head Trust. Want deeper insights into Atlassian's valuation and financial health? InvestingPro subscribers have access to 10+ additional ProTips and comprehensive financial analysis through the Pro Research Report.
In other recent news, Atlassian Corporation has seen significant developments. The company started fiscal year 2025 robustly, with cloud revenue surging by 31%, outpacing the predicted 27%. This growth is primarily driven by the successful integration of AI capabilities across its cloud platform. Oppenheimer analysts, expressing confidence in Atlassian's growth, raised the company's price target to $300, maintaining an Outperform rating. Similarly, Piper Sandler increased Atlassian's stock price target to $310, retaining an Overweight rating, based on the company's strong performance and growth potential.
Atlassian also underwent board changes, announcing the retirement of Jay Parikh and the appointment of Christian Smith, effective January 1, 2025. Furthermore, the company launched Rovo, an AI-powered product, and introduced new offerings aimed at enhancing enterprise capabilities. Macquarie initiated coverage on Atlassian with a Neutral rating, citing a balance of upside and downside risks influencing the company's outlook.
These are recent developments that could impact Atlassian's future performance. Analysts from Oppenheimer and Piper Sandler have expressed optimism, while Macquarie maintains a more balanced view. As always, investors should monitor these developments closely.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.